Hepatic-derived BMP9 is involved in hepatic fibrosis-induced kidney injury through inhibition of renal VEGFA.

导出 LinkOut

翻译打印收藏纠错

第一作者： Le,Chen

第一单位： Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innova-tive Drugs, School of Pharmacy, Anhui Medical University, The Key Laboratory of Anti-inflammatory of Immune Medicines, Hefei, China; Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.

作者： Le,Chen ^[1] ; Ruonan,Wang ^[1] ; Xiaodong,Lv ^[1] ; Min,Kan ^[1] ; Hongtao,Zhang ^[1] ; Wei,Qiu ^[1] ; Shao,Chen ^[1] ; Jiuling,Zhao ^[1] ; Xin,Wen ^[1] ; Xiaoming,Meng ^[1] ; Hua,Wang ^[1] ; Hongmei,Zang ^[2]

作者单位： Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innova-tive Drugs, School of Pharmacy, Anhui Medical University, The Key Laboratory of Anti-inflammatory of Immune Medicines, Hefei, China; Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China. ^[1] Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innova-tive Drugs, School of Pharmacy, Anhui Medical University, The Key Laboratory of Anti-inflammatory of Immune Medicines, Hefei, China; Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China. Electronic address: zanghongmei@ahmu.edu.cn. ^[2]

关键词 Acute kidney injury Bone morphogenetic protein 9 Hepatic fibrosis Hepatofactor Liver-kidney crosstalk Vascular endothelial growth factor A